UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

Impact of dual mTORC1/2 mTOR kinase inhibitor AZD8055 on acquired endocrine resistance in breast cancer in vitro

Breast cancer research : BCR, 2014-01, Vol.16 (1), p.R12-R12, Article R12

2014

Volltextzugriff (PDF)

Biological effects of fulvestrant on estrogen receptor positive human breast cancer: short, medium and long‐term effects based on sequential biopsies

International journal of cancer, 2016-01, Vol.138 (1), p.146-159

2016

Volltextzugriff (PDF)

Knockdown of the small conductance Ca(2+) -activated K(+) channels is potently cytotoxic in breast cancer cell lines

British journal of pharmacology, 2016-01, Vol.173 (1), p.177

2016

Volltextzugriff (PDF)

Knockdown of the small conductance Ca2+‐activated K+ channels is potently cytotoxic in breast cancer cell lines

British journal of pharmacology, 2016-01, Vol.173 (1), p.177-190

2016

Volltextzugriff (PDF)

Knockdown of the small conductance Ca 2+ ‐activated K + channels is potently cytotoxic in breast cancer cell lines

British journal of pharmacology, 2016-01, Vol.173 (1), p.177-190

2016

Volltextzugriff (PDF)

A randomized trial to assess the biological activity of short-term (pre-surgical) fulvestrant 500 mg plus anastrozole versus fulvestrant 500 mg alone or anastrozole alone on primary breast cancer

Breast cancer research : BCR, 2013-03, Vol.15 (2), p.R18-R18, Article R18

2013

Volltextzugriff (PDF)

Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin β1

Breast cancer research : BCR, 2011-03, Vol.13 (2), p.R29-R29, Article R29

2011

Volltextzugriff (PDF)

erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines

Breast cancer research : BCR, 2011-09, Vol.13 (5), p.R93-R93, Article R93

2011

Volltextzugriff (PDF)

Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells

Breast cancer research : BCR, 2007-08, Vol.9 (4), p.R50-R50, Article R50

2007

Volltextzugriff (PDF)

Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin [beta]1

Breast cancer research : BCR, 2011-03, Vol.13, p.R29

2011

Volltextzugriff (PDF)

ADAM metalloproteases and EGFR signalling

Breast cancer research : BCR, 2003-01, Vol.5 (5), p.223-224, Article 223

2003

Volltextzugriff (PDF)

Expanding the therapeutic repertoire of epidermal growth factor receptor blockade: radiosensitization

Breast cancer research : BCR, 2003-01, Vol.5 (3), p.126-129, Article 126

2003

Volltextzugriff (PDF)

Understanding endocrine resistance: the critical need for sequential samples from clinical breast cancer and novel in vitromodels

Breast cancer research : BCR, 2005-07, Vol.7 (5), Article 187

2005

Volltextzugriff (PDF)

Understanding endocrine resistance: the critical need for sequential samples from clinical breast cancer and novel in vitro models

Breast cancer research : BCR, 2005-01, Vol.7 (5), p.187-189

2005

Volltextzugriff (PDF)

Heregulin beta1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells

Breast cancer research : BCR, 2007, Vol.9 (4), p.R50-R50

2007

Volltextzugriff (PDF)

The problem of trastuzumab (Herceptin) resistance: a role for IGF-1R?

Breast cancer research : BCR, 2002-12, Vol.4 (1), p.75500-75500, Article 75500

Gee, Julia MW

2002

Volltextzugriff (PDF)

bcl-2: a convergence point for multiple signal transduction pathways that influence cell survival?

Breast cancer research : BCR, 2002-12, Vol.4 (1), p.74403-74403, Article 74403

Gee, Julia MW

2002

Volltextzugriff (PDF)

AKT signalling implicated in failure of endocrine therapy

Breast cancer research : BCR, 2002-12, Vol.4 (1), p.76350-76350, Article 76350

Gee, Julia MW

2002

Volltextzugriff (PDF)

Chaperone-mediated destruction of erbB2: relevance to tyrosine kinase inhibitors

Breast cancer research : BCR, 2002, Vol.4 (5), p.205-206, Article 205

Gee, Julia M W

2002

Volltextzugriff (PDF)

Extreme growth factor signalling can promote oestrogen receptor-alpha loss: therapeutic implications in breast cancer

Breast cancer research : BCR, 2004-01, Vol.6 (4), p.162-163, Article 162

2004

Volltextzugriff (PDF)

Insulin-like growth factor-I receptor signaling and resistance in breast cancer

Expert Review of Endocrinology & Metabolism, 2006-01, Vol.1 (1), p.33-46

2006

Volltextzugriff (PDF)

Plants and Animals Share Functionally Common Bacterial Virulence Factors

Proceedings of the National Academy of Sciences - PNAS, 2000-08, Vol.97 (16), p.8815-8821

2000

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)
Japanisch
(1)

Erscheinungsjahr

n.n

Kollektion

8 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of dual mTORC1/2 mTOR kinase inhibitor AZD8055 on acquired endocrine resistance in breast cancer in vitro

Biological effects of fulvestrant on estrogen receptor positive human breast cancer: short, medium and long‐term effects based on sequential biopsies

ELF5 suppresses estrogen sensitivity and underpins the acquisition of antiestrogen resistance in luminal breast cancer

Knockdown of the small conductance Ca(2+) -activated K(+) channels is potently cytotoxic in breast cancer cell lines

Knockdown of the small conductance Ca2+‐activated K+ channels is potently cytotoxic in breast cancer cell lines

Knockdown of the small conductance Ca 2+ ‐activated K + channels is potently cytotoxic in breast cancer cell lines

A randomized trial to assess the biological activity of short-term (pre-surgical) fulvestrant 500 mg plus anastrozole versus fulvestrant 500 mg alone or anastrozole alone on primary breast cancer

Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin β1

erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines

Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells

ELF5 Drives Lung Metastasis in Luminal Breast Cancer through Recruitment of Gr1+ CD11b+ Myeloid-Derived Suppressor Cells: e1002330

Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin [beta]1

ADAM metalloproteases and EGFR signalling

Expanding the therapeutic repertoire of epidermal growth factor receptor blockade: radiosensitization

Understanding endocrine resistance: the critical need for sequential samples from clinical breast cancer and novel in vitromodels

Understanding endocrine resistance: the critical need for sequential samples from clinical breast cancer and novel in vitro models

Heregulin beta1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells

The problem of trastuzumab (Herceptin) resistance: a role for IGF-1R?

bcl-2: a convergence point for multiple signal transduction pathways that influence cell survival?

AKT signalling implicated in failure of endocrine therapy

Chaperone-mediated destruction of erbB2: relevance to tyrosine kinase inhibitors

Extreme growth factor signalling can promote oestrogen receptor-alpha loss: therapeutic implications in breast cancer

Insulin-like growth factor-I receptor signaling and resistance in breast cancer

Plants and Animals Share Functionally Common Bacterial Virulence Factors

Suchergebnisse filtern